Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/24/2010CA2548457C Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same
08/24/2010CA2536206C Pharmaceutical products comprising bisphosphonates
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2462510C Wipe formulation
08/24/2010CA2459011C A bio-security system
08/24/2010CA2450900C Drug activation process and vibrational mill therefor
08/24/2010CA2427520C Hydrophilic polymer blends used for dry cow therapy
08/24/2010CA2426883C Methylphenidate modified release formulations
08/24/2010CA2386932C Dispersion with nonionic emulsifier
08/24/2010CA2386278C Dip coating compositions containing starch or dextrin
08/24/2010CA2377560C Incorporation and applications of biomolecular interactions within a carrier
08/24/2010CA2362757C Effervescent pharmaceutical formulation containing metamizole
08/24/2010CA2213560C Pharmaceutical compositions for controlled release of soluble receptors
08/24/2010CA2172509C Methods and compositions for microencapsulation of antigens for use as vaccines
08/19/2010WO2010093944A2 Delayed release, oral dosage compositions that contain amorphous cddo-me
08/19/2010WO2010093941A2 COMPOSITIONS AND METHODS FOR MINIMALLY-INVASIVE SYSTEMIC DELIVERY OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS
08/19/2010WO2010093925A2 PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
08/19/2010WO2010093873A2 Drug delivery through hydrogel plugs
08/19/2010WO2010093799A1 Method of treating vascular disease at a bifurcated vessel using a coated balloon
08/19/2010WO2010093629A1 Par-1 antagonism in fed or antacid-dosed patients
08/19/2010WO2010093627A2 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010WO2010093564A1 Valproic acid drug delivery systems and intraocular therapeutic uses thereof
08/19/2010WO2010093561A1 Particulate composition and the method of making the same
08/19/2010WO2010093528A2 On-demand and reversible drug release by external cue
08/19/2010WO2010093523A2 Foamable microemulsion compositions for topical administration
08/19/2010WO2010093460A2 Particle size-structured parenteral dispersions
08/19/2010WO2010093452A2 Reducible polymers for non-viral gene delivery
08/19/2010WO2010093374A1 Compositions and methods for treating post-operative pain using bupivacaine and an anti-inflammatory agent
08/19/2010WO2010093285A1 Composition comprising biodegradable carrier for controlled drug delivery
08/19/2010WO2010093020A1 Hard capsule
08/19/2010WO2010092925A1 Solid dispersion, pharmaceutical composition comprising the solid dispersion, and processes for producing the solid dispersion and the pharmaceutical composition
08/19/2010WO2010092828A1 Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
08/19/2010WO2010092597A2 Liposomal citicoline injection
08/19/2010WO2010092596A1 An oral pharmaceutical composition of dutasteride
08/19/2010WO2010092534A1 Compositions for the treatment of aphthous stomatitis
08/19/2010WO2010092462A1 Textile article for patients affected by a skin disease
08/19/2010WO2010092163A2 Antidiabetic medications
08/19/2010WO2010092126A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010WO2010092088A2 Use of hydrophobin as a spreading agent
08/19/2010WO2010091822A2 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
08/19/2010WO2010091683A2 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
08/19/2010WO2010091649A2 A composition for buccal absorption of nicotine for the purpose of smoking cessation
08/19/2010WO2010077671A3 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
08/19/2010WO2010072421A3 Hydrogel composition for the treatment of dermatological disorders
08/19/2010WO2010072420A3 Compositions comprising hemp oil for treating topical diseases, especially hand-foot syndrome
08/19/2010WO2010070589A3 A novel dermaceutical cream made using sodium fusidate
08/19/2010WO2010070057A3 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
08/19/2010WO2010066034A8 Narcotic drug formulations with decreased abuse potential
08/19/2010WO2010058924A3 Fast dissolving oral tablets and method for production thereof
08/19/2010WO2010056754A3 Inhibition of mammalian target of rapamycin
08/19/2010WO2010054326A3 C-terminal fragments of glucagon-like peptide-1 (glp-1)
08/19/2010WO2010053306A3 Pharmaceutical composition for the controlled release of methylphenidate
08/19/2010WO2010051918A3 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
08/19/2010WO2010048623A8 Medical and imaging nanoclusters
08/19/2010WO2010045281A3 Stable aqueous formulations of water insoluble or poorly soluble drugs
08/19/2010WO2010045209A9 Methods of treating pulmonary disorders with liposomal amikacin formulations
08/19/2010WO2010044070A3 Synergistic composition for recovery and reduction of mild ischemic damage
08/19/2010WO2010039798A3 Amorphous compositions of sunitinib base and l-malic acid
08/19/2010WO2010029095A3 Capsule with soluble blocking element
08/19/2010WO2010022293A3 Methods of processing compositions containing microparticles
08/19/2010WO2010018175A3 Oral pharmaceutical formulation for omeprazole comprising a specific separation layer
08/19/2010WO2010005732A8 Composition and method of preparation of release systems for constant (zero-order) release of active agents
08/19/2010WO2009135947A3 Process for preparing a low drug load tablet
08/19/2010US20100211183 Chemical Mechanical Vapor Deposition Device for Production of Bone Substitute Material
08/19/2010US20100210901 Devices, Systems and Methods For Diagnosing and Treating Sinusitis and Other Disorders of the Ears, Nose and/or Throat
08/19/2010US20100210729 Methods of inducing terminal differentiation
08/19/2010US20100210717 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
08/19/2010US20100210626 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
08/19/2010US20100210615 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210614 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210609 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
08/19/2010US20100210600 Methods and Compositions for Treating Urogenital Disorders
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209526 Product comprising a combination of milk serum apoproteins and free fatty acids
08/19/2010US20100209525 Methods for preparing polymer microparticles
08/19/2010US20100209524 Encapsulated agglomeration of microcapsules and method for the preparation thereof
08/19/2010US20100209523 Powder composition
08/19/2010US20100209522 Embolization
08/19/2010US20100209521 Sensory pigmets used on food, packaging, paper and pharmaceutical and electronic products
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209519 Pharmaceutical composition for inhalation delivery and fabrication method thereof
08/19/2010US20100209518 Micro-particles, blood-substitute and method for forming same
08/19/2010US20100209517 Analgesic and anti-inflammatory compositions comprising domperidone and methods of using same
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209515 Electricity-generating particulates and the use thereof
08/19/2010US20100209514 Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209513 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
08/19/2010US20100209512 Particle size-structured parenteral dispersions
08/19/2010US20100209511 sustained release pharmaceutical formulation
08/19/2010US20100209510 Extended Release Formulation and Method of Treating Adrenergic Dysregulation
08/19/2010US20100209509 Bifunctional-modified hydrogels
08/19/2010US20100209508 Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209506 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/19/2010US20100209505 Controlled release pharmaceutical formulations of nitazoxanide
08/19/2010US20100209504 Process for production of crystalline cellulose and tablets containing granules
08/19/2010US20100209503 Bitter Taste Masking Dosage Form
08/19/2010US20100209502 Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity
08/19/2010US20100209501 Controlled release budesonide minitablets
1 ... 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 ... 2991